Sharps Technology shares are trading higher Thursday after the company announced it has received a signed $30 million purchase order from Nephron Pharmaceuticals. Here's a look at the details:
Sharps Technology shares are trading higher by 60.8% during Thursday's session. The company signed a 5-year $200 million syringe sales agreement with Nephron Pharmaceuticals.
Shares of Pure Storage, Inc. (NYSE:PSTG) rose sharply in today’s pre-market trading following better-than-expected first-quarter financial results. Pure…